S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

CMND Clearmind Medicine Inc

1.51

0.02 (1.34%)

25 Jan 2025 - Closed

Delayed by 15 minutes

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Clearmind Medicine (NASDAQ:CMND)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Clearmind Medicine Charts.

Clearmind Medicine (NASDAQ:CMND)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Clearmind Medicine Charts.

Clearmind Medicine Inc News

Form POS AM - Post-Effective amendments for registration statement
Thursday 23 January 2025 (4 days ago) • Edgar (US Regulatory)

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Thursday 23 January 2025 (4 days ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 8 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Clearmind Medicine Announces Shareholders Meeting Results
Wednesday 8 January 2025 (3 weeks ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 7 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Clearmind Medicine Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment
Tuesday 7 January 2025 (3 weeks ago) • GlobeNewswire Inc.

SciSparc-Clearmind Medicine Collaboration Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment
Monday 6 January 2025 (3 weeks ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 3 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Clearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property Office
Thursday 2 January 2025 (4 weeks ago) • GlobeNewswire Inc.

Clearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol Substitute
Thursday 26 December 2024 (1 month ago) • GlobeNewswire Inc.

Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical Trial
Tuesday 24 December 2024 (1 month ago) • GlobeNewswire Inc.

Clearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet for Mutual Development of Novel Psychedelic MEAI- Based Alcohol Substitute in ActivCrystal™ Format
Tuesday 17 December 2024 (1 month ago) • GlobeNewswire Inc.

More Clearmind Medicine Inc News Articles

Solitron Devices (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions